Evaluation of HDAC8 as a Druggable Target in STAG2 -Mutant Ewing Sarcoma
Open Access
- 26 August 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 21 (9) , 2188-2199
Abstract
Ewing sarcoma is an aggressive pediatric cancer for which no targeted therapies have been approved. This disease is driven by EWSR1::ETS family fusions that, like most fusion transcription factors, have proven difficult to target directly. Here, we focus on identifying actionable dependencies within the high-risk STAG2-mutant (STAG2-mut) disease subtype of Ewing sarcoma. In STAG2-mut Ewing sarcoma, STAG1 knockout is synthetically lethal but is not readily druggable. Using the Cancer Dependency Map (DepMap), we identify histone deacetylase 8 (HDAC8) as an enriched vulnerability in this molecular context. CRISPR validation and a newly developed HDAC8 degrader, XY-09-36, confirm this selective dependency and suggest increased reliance on HDAC8-mediated cohesin regulation when STAG2 is lost. These findings establish HDAC8 as a context-dependent, pharmacologically accessible vulnerability and outline a framework for discovering rational targets in tumor subtypes where primary drivers are intrinsically hard to drug.Keywords
Funding Information
- National Cancer Institute
- American Cancer Society
- National Institutes of Health (NIH)
- Elsa Pardee Foundation
- Lubin Family Foundation Fellowship Award
This publication has 53 references indexed in Scilit:
- Discovery of highly potent HDAC8 PROTACs with anti-tumor activityBioorganic Chemistry, 2023
- Chemo-proteomics exploration of HDAC degradability by small molecule degradersCell Chemical Biology, 2021
- TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcomaCancer Cell, 2021
- STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcomaCancer Cell, 2021
- STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcomaCancer Cell, 2021
- Cohesin Loss Eliminates All Loop DomainsCell, 2017
- Defining a Cancer Dependency MapCell, 2017
- The Cohesin Release Factor WAPL Restricts Chromatin Loop ExtensionCell, 2017
- RAD21 Mutations Cause a Human CohesinopathyThe American Journal of Human Genetics, 2012
- The Biology of Ewing sarcomaCancer Letters, 2007